Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults.

Shi, Shanshan; Jiang, Yizhou; Chen, Weihua; Chen, Kaihong; Liao, Ying; Huang, Kun

Shi, Shanshan; Jiang, Yizhou; Chen, Weihua; Chen, Kaihong; Liao, Ying; Huang, Kun.

Afiliação

Shi S; Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Jiang Y; Department of Internal Medicine, The Third Clinical Medical College, Fujian Medical University, Longyan, China.
Chen W; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen K; Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Liao Y; Department of Internal Medicine, The Third Clinical Medical College, Fujian Medical University, Longyan, China.
Huang K; Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.

Front Nutr ; 9: 897774, 2022.

Article em En | MEDLINE | ID: mdl-36017221

Palavras-chave

Creatinine/Cystatin C ratio; creatinine; cystatin C; low muscle mass; mortality; sarcopenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google